Form 4 for IMDX Insight Molecular Diagnostics Inc.
Accepted 2022-03-17 00:00:00 ET · period of report 2022-03-15 · accession 0001493152-22-007205 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-17 | 2022-03-16 | IMDX | ANDREWS RONALD ASBURY | CEO, Dir | P - Purchase | $1.28 | +50.0K | 293.2K | +21% | +$64.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, no par value | 2022-03-16 | P | A | 50,000 | $1.28 | 293,212 | D | — | — |